Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-08-25 Capital/Financing Update
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a detailed credit rating update from ICRA Limited regarding Torrent Pharmaceuticals Limited. It discusses the upgrade of long-term credit ratings, reaffirmation of short-term ratings, and the rationale behind these changes. The content includes extensive financial performance analysis, business segment details, market share, profitability, liquidity, and credit challenges. It is not a brief announcement but a comprehensive credit rating rationale report. The document references regulatory bodies (SEBI, USFDA), specific financial instruments (non-convertible debentures, commercial paper), and detailed financial metrics and outlooks. It does not fit into categories like Earnings Release, Annual Report, or Interim Report, as it focuses on credit rating information. The closest fitting category is Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including credit rating changes. Therefore, the document should be classified as CAP with high confidence.
2022-08-25 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short notice dated 9th August 2022 from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE). It informs about the schedule of an Investors Meet (Pharma Conference) on August 10, 2022, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is an announcement of an upcoming investor event rather than a detailed report or financial statement. The document length is only 1327 characters, indicating it is a brief notification. There is no financial data, no detailed presentation, no voting results, no management discussion, or other report content. This fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice under SEBI regulations.
2022-08-09 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice dated 9th August 2022 from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE). It informs about the schedule of an Investors Meet (Pharma Conference) on August 10, 2022, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is an announcement of participation in an investor event, not a financial report, earnings release, or detailed presentation. It is brief (1327 characters) and serves as a regulatory disclosure of an upcoming investor meeting. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2022-08-09 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the completion of dispatch of a Postal Ballot Notice to shareholders. It references compliance with the Companies Act, SEBI Listing Regulations, and mentions newspaper advertisements as proof of dispatch. The document is short (1995 characters) and serves as an announcement of a procedural step related to shareholder voting, not the actual Postal Ballot Notice or voting results. It does not contain financial data, management discussion, or voting results. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2022-08-09 English
Newspaper advertisement for completion of dispatch of Postal Ballot Notice
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the completion of dispatch of a Postal Ballot Notice to shareholders. It references compliance with the Companies Act, SEBI Listing Regulations, and Ministry of Corporate Affairs circulars. The content includes details about the dispatch date, cut-off date for shareholders, and e-voting schedule. It also encloses newspaper cuttings as proof of dispatch. There is no financial data, earnings information, or management discussion. The document is an announcement related to shareholder voting procedures and the dispatch of voting materials, not the voting results or the actual postal ballot report. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is about the dispatch of the Postal Ballot Notice and not the solicitation materials themselves or the voting results, it is more aligned with a Regulatory Filing (RNS) as a general regulatory announcement about compliance and procedural update. Given the detailed regulatory references and the nature of the announcement, the best classification is Regulatory Filings (RNS).
2022-08-09 English
In furtherance of our intimation dated 29th July, 2022 and in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed ....
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of a Postal Ballot issued by Torrent Pharmaceuticals Limited. It includes information about the appointment of directors, remuneration details, voting instructions, and compliance with relevant regulations such as the Companies Act, SEBI Listing Obligations, and MCA circulars. The document is not a report of voting results but a notice inviting shareholders to vote on specific resolutions via e-voting. It is not an annual report, earnings release, or any other financial report but a formal communication related to shareholder voting procedures and proposed resolutions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) only if it contained results, but since it is a notice of the postal ballot (invitation to vote), it is best classified as a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or ballots.
2022-08-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.